What we know about the personalized mRNA cancer vaccine
Merck and Moderna announced a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients with melanoma.
Copyright © 2026 KABC Television, LLC. All rights reserved.
